Results 281 to 290 of about 564,426 (377)

Causes of death in people living with HIV from a North London cohort between 2006 and 2023: A descriptive analysis

HIV Medicine, EarlyView.
Abstract Background The provision of highly active anti‐retroviral therapy has improved outcomes for people with HIV, worldwide. There are few data on trends and changes in the cause of death among people with HIV in the United Kingdom since its advent.
Linda Cheyenne Vaccari, Damien K. Ming, Jane Hazell, Alan Hunter, Fiona M. Burns, Robert F. Miller   +5 more
wiley   +1 more source

Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma. [PDF]

Cancers (Basel)
Alibrahim MN, Gloghini A, Carbone A.
europepmc   +1 more source

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real‐world effectiveness remain limited. This study aimed to assess real‐world outcomes of oral MTX in the treatment of MF. Data from five referral centres for cutaneous lymphoma in Greece were retrospectively reviewed with the baseline‐ and ...
Vasiliki Nikolaou, Evdoxia Panou, Antonios Tsimpidakis, Ioannis‐Alexios Koumprentziotis, Aikaterini Patsatsi, Marina Siakantaris, Sabine‐Elke Kruger‐Krasagakis, Leonidas Marinos, Elisavet Georgiou, Kyriaki Lampadaki, Aliki Velissari, Athina‐Ioanna Daponte, Aikaterini Doxastaki, Stella Kaliampou, Aristeidis Vaiopoulos, Iliana Konstandinou, Marios Koumourtzis, Eleftheria Lakiotaki, Vassiliki Pappa, Athanasios Tsamaldoupis, Alexander Stratigos, Evangelia Papadavid   +21 more
wiley   +1 more source

Newly Diagnosed Classical Hodgkin Lymphoma: Optimizing Outcomes in a New Therapeutic Era. [PDF]

Hematol Oncol
Evens AM.
europepmc   +1 more source

Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas

, 2000
M. Herranz, Miguel Urioste, Javíer Santos, JB Martinez-Delgado, Carmen Rivas, Javier Benı́tez, José Fernández‐Piqueras   +6 more
openalex   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

Synchronous presentation of Hodgkin lymphoma and papillary thyroid carcinoma in a young patient: a case review. [PDF]

J Surg Case Rep
Aldeligan SH, AlQahtani AS, Aljunaydil A, Alzahrani N, Alakeel F, Althobaiti BT, Bokhari A.   +6 more
europepmc   +1 more source

Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study identifies a progressive decline in overall survival with each 10% increase in BSA in early‐stage mycosis fungoides. A new BSA cut‐off of 40% is proposed as a significant prognostic factor for patients with patch/plaque‐stage disease, with potential therapeutic consequences.
Juliette M. Kersten, Rosanne Ottevanger, Koen D. Quint, Maarten H. Vermeer, Jelle J. Goeman, Youn Kim, Felicity Evison, Julia J. Scarisbrick, Rein Willemze   +8 more
wiley   +1 more source

Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States. [PDF]

Sci Rep
Mousavi SE, Najafi M, Aslani A, Ghasemi H, Yekta Z, Nejadghaderi SA.   +5 more
europepmc   +1 more source

Cancer and Accelerated Aging Research at the National Institutes of Health, 2013–2023: A Grant Portfolio Analysis

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background The purpose of this study was to describe the characteristics of the NIH‐funded grant portfolio focused on cancer and accelerated aging. Methods Research project grants focused on cancer survivors and aging trajectories that were newly funded during fiscal years 2013 through 2023 were identified by first using a text mining ...
Lisa Gallicchio, Rachelle Brick, Gina Tesauro, Lindsey Page, Paige Green, Jennifer L. Guida   +5 more
wiley   +1 more source